Halozyme Therapeutics Inc. buy Benchmark Co.
Start price
20.02.25
/
50%
€54.68
Target price
20.02.26
€71.72
Performance (%)
22.38%
Price
13.02.26
€66.92
This prediction will end soon
Summary
This prediction is currently active. The prediction currently has a performance of 22.38%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | -2.591% | -2.591% |
| iShares Core DAX® | 0,46 % | -2,00 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % |
| iShares S&P 500 | -1,76 % | -3,67 % |
Comments by Benchmark_Co_ for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $75.00 price target on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€64.40
03.02.26
03.02.26
-
03.02.27
03.02.27
3.91%
13.02.26
13.02.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€66.40
24.09.25
24.09.25
€76.27
24.09.26
24.09.26
0.78%
13.02.26
13.02.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.87
08.08.24
08.08.24
€55.00
08.08.25
08.08.25
10.25%
09.08.25
09.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.68
25.06.24
25.06.24
€56.00
25.06.25
25.06.25
-7.99%
26.06.25
26.06.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.23
16.04.24
16.04.24
€46.98
16.04.25
16.04.25
43.42%
17.04.25
17.04.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.35
19.01.24
19.01.24
€45.94
19.01.25
19.01.25
69.19%
20.01.25
20.01.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.23
20.10.23
20.10.23
€47.17
20.10.24
20.10.24
45.44%
21.10.24
21.10.24